Skip to main content
. 2015 Jul 30;10:132. doi: 10.1186/s13000-015-0364-3

Fig. 1.

Fig. 1

The study workflow. All cases were tested by the KRAS LCD-array Kit and MALDI MS. If a mutation was found by the KRAS LCD-array Kit, a report was signed out. If no mutation was detected by the KRAS LCD-array Kit, that covers exclusively exon 2, Sanger sequencing has been performed for KRAS, NRAS and BRAF in exon 2–4 and a report was signed out accordingly